CENTER ID: | AcbaC.17231.a |
ORGANISM: | Acinetobacter baumannii AB5075-UW |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
unclassified |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
AcbaC.17231.a.B1.GE38746 | full length | 1 | 371 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
AcbaC.17231.a.B1.PS38072 | full length | 1 | 371 |
RESOURCE | REFERENCE ID |
---|---|
BV-BRC: | fig|470.1345.peg.3312 |
GenBank: | AKA33073.1 |
PGAT: | acinetobacter:ABUW_3377 |
RefSeq: | WP_000572095.1 |
UniProt: | V5VGK9 |
HARVESTED ON: | 1/22/2015 |
SEQUENCED ON: | 1/15/2015 |
EXPECTED MW: | 41kDa |
OBSERVED MW: | 41kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 97 |
PURIFICATION DATe: | 10/12/2016 |
CONCENTRATION: | 31.2mg/ml |
OBSERVED MW: | 40kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | SEC |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 1 |
VIAL VOLUME: | 100µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 97 |